What does CUSIP 60770K107 represent in this 13F holders report?

CUSIP 60770K107 is the security identifier for MRNA - Moderna, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held MRNA - Moderna, Inc. - COMMON STOCK in Q1 2019?

101 institutional investors reported MRNA - Moderna, Inc. - COMMON STOCK for Q1 2019. Use the holders table for investor-level position and value details.

Moderna, Inc. - COMMON STOCK (MRNA)

CUSIP: 60770K107

Q1 2019 13F Holders as of 31 Mar 2019

Security type / class: Equity / COMMON STOCK
Total 13F shares: 79,523,801
Total 13F value: $1,604,234,442
Share change: +4,731,548
Put/Call ratio: 99%
SEC-reported price per share: $20.35
Number of holders: 101
Value change: +$101,479,383
Number of buys: 66
Number of sells: 39
Shares outstanding: 395,449,552

Security key

60770K107

Report period

Q1 2019

Institutions

101

Top holders

MRNA full security history Ownership snapshot Full 13F holder table Moderna, Inc. SEC filings Moderna, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MRNA - Moderna, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Flagship Pioneering, LLC

Disclosed value leader

Flagship Pioneering, LLC

Comparable rows

15/15

Latest evidence

31 Dec 2018

13F Lead comparable stake: 15% Showing 1-6 of 15 holder rows.

Quick read

Flagship Pioneering, LLC leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Flagship Pioneering, LLC's linked filing trail.

Comparable ownership Top 5

Flagship Pioneering, LLC 15%

VIKING GLOBAL INVESTORS LP 4.3%

FMR LLC 3.9%

Artal Group S.A. 1.3%

BB BIOTECH AG 1.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Flagship Pioneering, LLC	13F Company 13F	15%	$897,989,000 58,807,379 shares	—	31 Dec 2018
VIKING GLOBAL INVESTORS LP	13F Company 13F	4.3%	$260,829,000 17,081,164 shares	—	31 Dec 2018
FMR LLC	13F Company 13F	3.9%	$213,158,000 15,276,445 shares	—	31 Dec 2018
Artal Group S.A.	13F Company 13F	1.3%	$80,264,000 5,256,298 shares	—	31 Dec 2018
BB BIOTECH AG	13F Company 13F	1.2%	$73,077,000 4,785,681 shares	—	31 Dec 2018
FIDUCIARY TRUST CO	13F Company 13F	1.1%	$65,843,000 4,311,927 shares	—	31 Dec 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

101

79,523,801

Rows available

101

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2019 vs Q1 2019 Across Filers

Q1 2019 holders

101

Q1 2019 holders

101

Holder diff

Investor	Q1 2019 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q1 2019 value	Value change	Value Chg %